- Ongoing, recruitingTherapeutic exploratory (Phase II)
Comparison of 18F-Fluciclovine PET versus 18F-Fluoroethyltyrosine PET in patients with newly diagnosed cerebral gliomas, recurrent cerebral gliomas and brain metastases – an open label single centre single arm prospective basket trial
This study compares two types of special body scans (PET scans) for people with brain tumours. It looks at how well these scans show the size and spread of tumours, aiming to see if one scan, Axumin, works as well as or better than another, FET. This could help doctors in the future.
For: Patients with newly diagnosed cerebral gliomas · recurrent cerebral gliomas and brain metastases.Germany - AuthorisedTherapeutic confirmatory (Phase III)
Use of [18F]FET PET-MRI to improve detection of pituitary adenomas in Cushing’s disease
This study is testing a new type of scan called FET PET-MRI for people with Cushing's disease. We want to see if it's better than the current standard test at finding the problem in the pituitary gland, which causes too much cortisol. This could help doctors diagnose and treat the condition more accurately.
For: ACTH-dependent hypercortisolismNetherlands